Cytotoxic flavokawain B inhibits the growth and metastasis of hepatocellular carcinoma through UCK2 modulation of the STAT3/Hif-1α/VEGF signalling pathway.
Ibrahim MalamiAlhassan AlhassanAdamu AdamuMuhammad BelloAliyu MuhammadMustapha ImamPublished in: Current drug targets (2023)
Our data suggest that FKB inhibited HepG2 proliferation and further suppressed its metastasis partly by regulating the STAT3/Hif-1α/VEGF signalling pathway. FKB could be a potential alternative and viable strategy against HCC.